Johnson & Johnson — leaders in healthcare innovation, where treatments are smarter and less invasive, and solutions are ...

FY 2024 total sales growth of 9.9% at CER1, or 8.7% as reported, with growth driven by strong performance across all therapeutic areas, including ...

People with metastatic cancer who regularly report their symptoms via a home-based electronic monitoring system experienced ...

Although the prevalence of substance use disorder increased during the COVID-19 pandemic, the receipt of treatment declined ...

Among children with high BP, there are racial and ethnic disparities in receipt of nutrition, lifestyle, and weight counseling.

PureWow editors select every item that appears on this page, and some items may be gifted to us. Additionally, PureWow may ...

Kei Igarashi, Chancellor’s Fellow and associate professor of anatomy and neurobiology at the University of California, Irvine School of Medicine, has been named 1 of 5 recipients of the 2024 Inoue ...

Q After our doctors discuss pets’ dental diagnoses with clients, we email them estimates. A small number of clients call to ...

In a turbulent market environment, SCLX stock has reached a 52-week low, trading at $0.33, with a market capitalization of $62.12 million. This price level reflects a significant downturn for the ...

NAFDAC, sealed the popular Idumota drug market in Lagos as part of its nationwide operation to combat the distribution of ...

OK, introduced the Ensuring Accountability and Dignity in Government Contracting Act of 2025 to close gaps in federal rules ...

Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) missed Wall Street’s revenue expectations in Q4 CY2024, with sales ...